Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019

BACKGROUND: Patients with multiple myeloma (MM) remain at an increased risk of infection due to the disease process, as well as the ensuing treatments. METHODS: We performed a systematic review to evaluate the monthly risk of grade III/IV infection, pneumonia, and neutropenia in patients with myelom...

Descripción completa

Detalles Bibliográficos
Autores principales: Balmaceda, Nicole, Aziz, Muhammad, Chandrasekar, Viveksandeep Thoguluva, McClune, Brian, Kambhampati, Suman, Shune, Leyla, Abdallah, Al-Ola, Anwer, Faiz, Majeed, Aneela, Qazilbash, Muzaffar, Ganguly, Siddhartha, McGuirk, Joseph, Mohyuddin, Ghulam Rehman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233183/
https://www.ncbi.nlm.nih.gov/pubmed/34172037
http://dx.doi.org/10.1186/s12885-021-08451-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233183/
https://www.ncbi.nlm.nih.gov/pubmed/34172037
http://dx.doi.org/10.1186/s12885-021-08451-x

Ejemplares similares